Related Experiment Video
Updated: Jul 18, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome
Agshin F Taghiyev1, Natalya V Guseva, Rebecca A Glover
1Department of Pathology, The University of Iowa, Iowa City, Iowa 52242-1087, USA.
Abstract:
The histone deacetylase inhibitor Trichostatin A (TSA) has previously been found to induce caspase activity in the human prostate cancer cell lines DU145 and LNCaP. TSA treatment resulted in the release of cytochrome c and Smac/DIABLO from mitochondria in DU145, and activation of caspase-9 in both cell lines. We concluded that TSA mediated its effect via the mitochondrial pathway. The aim of the current study was to determine how TSA initiated the caspase cascade. The results revealed that caspase-2 plays an important role in TSA-induced apoptosis. Inhibition of caspase-2 by siRNA or expression of caspase-2dn substantially decreased caspase activity after TSA treatment in both cell lines, siRNA caspase-2 also inhibited TSA-induced cell death. Caspase-2 acts upstream of caspase-8 and -9 and mediates mitochondrial cytochrome c release. Coimmunoprecipitation experiments show that caspase-2 formed protein complexes with RADD/RAIDD and PIDD. Together, these data indicate that caspase-2 initiates caspase cascade after TSA treatment and involves the formation of the PIDDosome.
Insights
Trichostatin A (TSA) triggers apoptosis in prostate cancer cells by activating caspase-2. This initiates the mitochondrial pathway, leading to cell death and involving PIDDosome formation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Histone deacetylase inhibitors like Trichostatin A (TSA) induce apoptosis in cancer cells.
- TSA activates caspases and triggers the mitochondrial pathway in prostate cancer cells.
Purpose of the Study:
- To elucidate the upstream mechanisms by which TSA initiates the caspase cascade in prostate cancer cells.
- To determine the role of caspase-2 in TSA-induced apoptosis.
Main Methods:
- Utilized siRNA and dominant-negative caspase-2 (caspase-2dn) to inhibit caspase-2 activity.
- Assessed caspase activity, cytochrome c release, and cell viability post-TSA treatment.
- Performed coimmunoprecipitation to identify caspase-2 interacting proteins.
Main Results:
- Inhibition of caspase-2 significantly reduced TSA-induced caspase activity and cell death.
- Caspase-2 was found to act upstream of caspase-8 and -9, mediating mitochondrial cytochrome c release.
- Caspase-2 formed protein complexes with RADD/RAIDD and PIDD, indicating PIDDosome involvement.
Conclusions:
- Caspase-2 is a critical initiator of the caspase cascade in TSA-treated prostate cancer cells.
- The findings highlight the role of the PIDDosome complex in TSA-induced apoptosis via the mitochondrial pathway.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Caspases
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy
